Mammotome

Mammotome At Mammotome, our expertise and compassion for breast care makes us the indispensable partner to physicians, clinicians, and patients.

Our global team is committed to developing and distributing breakthrough technologies in breast care. With over 30 years as a trusted leader, we boast a comprehensive range of products that create better outcomes in breast care and provide physicians, clinicians and patients with educational resources that guide their journey. Our drive for innovation is rivaled only by our compassion for the peop

le we serve, from the clinicians and surgeons who demand consistently precise solutions, to the patients and families seeking peace of mind. Headquartered in Cincinnati, OH, the Mammotome brand is sold in over 50 different countries throughout the world. We firmly believe that our employees drive the company’s success, and strive to provide an environment that offers challenging, stimulating and financially rewarding opportunities. Our associates know that every moment matters when it comes to advancing breast care diagnostics and surgical solutions. As an employee of our organization, you will be consistently challenged to deliver your best, and we’re passionate about retaining, developing and recruiting highly qualified and diverse candidates. Mammotome is proud to be part of Danaher. Danaher is a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. Together, we partner with customers to solve their toughest challenges—with speed and certainty. Social media terms of use at: https://www.mammotome.com/social-media-guidelines/

08/27/2026

Marker displacement can create challenges during localization and surgical excision.

The HydroMARK™ Plus markers feature wings that are designed to anchor to tissue and help mitigate displacement during surgical excision.[1]

Watch breast surgeon Dr. Anjeanette Brown demonstrate how the Dragonfly™ marker remains securely attached during localization and specimen handling and learn how the HydroMARK™ Plus marker portfolio provides confidence when you need it most.

Watch the video here: https://ow.ly/5LPB50ZG4fj



1. HydroMARK™ Device Test - PCR-000299, SDR0098 Vacuum Suction Testing.

08/26/2026

The national shortage of stereotactic breast biopsy needles continues to impact providers and patient access to timely diagnostic care.

At Mammotome, we’ve expanded manufacturing capacity, increased production shifts, and accelerated support for efforts to help healthcare providers maintain access to critical breast biopsy procedures.

Learn more about the actions we’re taking to help providers navigate the shortage and maintain access to critical breast biopsy procedures.

Read the full update: https://ow.ly/pi8I50ZFEZa

08/20/2026

When it comes to breast surgery, precision isn't just important—it's everything. That’s why Dr. Giblin trusts the Pintuition® System.

Discover why Dr. Giblin relies on the Pintuition® System as a powerful navigational tool in breast surgical oncology. Learn more: https://ow.ly/92Oz50ZB6zS

Mammotome was proud to participate in the Karen Wellington Foundation for Living with Breast Cancer’s 5th Annual FUN Run...
08/19/2026

Mammotome was proud to participate in the Karen Wellington Foundation for Living with Breast Cancer’s 5th Annual FUN Run 5K! 💜

Our team was honored to support an incredible mission: creating joyful experiences for women and families affected by breast cancer. We’re grateful to be part of an event that celebrates hope, resilience, and lasting memories.

08/13/2026

Discover biopsy markers as unique as your patients.

The Mammotome® Markers portfolio includes a comprehensive set of markers to meet your breast biopsy needs as well as the needs of your patients. Regardless of the type of lesion, breast density, care plan or sensitivities and preferences of your breast care patients, Mammotome® Markers offer a solution.

Follow the link to learn more. Link: https://ow.ly/VGAi50ZyUZq

08/12/2026

The Mammotome® Elite Tetherless Vacuum-Assisted Biopsy System makes it more efficient* to perform ultrasound-guided breast biopsies on even the most challenging lesions. Follow the link to learn how the Mammotome® Elite device can help improve accuracy** and confidence at your facility:

Link: https://ow.ly/KFUR50ZyH1T

*With TruVac™ technology
**Data comparing the 13G Mammotome® Elite system to a 14G core needle device

08/06/2026

See why the Neoprobe® GDS is a must-have tool for surgical precision. Watch Dr. Fana Explain how it supports sentinel lymph node biopsy.

“One of the challenging things in performing sentinel lymph node biopsy is that the axillary space is small and there are a lot of vital structures. Neoprobe® allows the surgery to happen accurately and efficiently.”

Learn more: https://ow.ly/KOqW50ZwFsL

07/16/2026

Reduce uncertainty in the OR with a marker designed to stay in place.

Intraoperative clip loss doesn’t just disrupt procedures, it can lead to:

• Increased tissue excision
• Longer surgical times
• Added stress for both clinicians and patients

The HydroMARK™ Plus Breast Biopsy Site Marker is designed to help minimize these challenges.

With Wings that Cling™ technology, the marker is engineered to:

✅ Enter the biopsy cavity first and anchor to surrounding tissue[1]
✅ Help mitigate displacement during surgical excision[1]
✅ Provide added confidence when precision matters most

The HydroMARK™ Plus marker supports reliability from biopsy through surgery.

See it in action and discover the difference: https://ow.ly/cNSo50ZmyK1

1. HydroMARK™ Device Test - PCR-000299, SDR0098 Vacuum Suction Testing

07/14/2026

Exciting news from ! We’re excited to share that the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System has received Health Canada clearance — an important milestone in expanding access to innovative MR-guided breast biopsy technology.

The Mammotome Prima™ MR system is the first in-room MR vacuum-assisted breast biopsy system designed to be used directly at the patient’s side, helping clinicians improve coordination, streamline communication, and stay focused on what matters most — the patient.

This clearance marks another step forward in our commitment to advancing breast care globally and bringing clinicians solutions designed for greater confidence, efficiency, and optimized patient care.

Learn more: https://ow.ly/UXHa50ZmxHX

07/02/2026

Visibility when it matters most: at every stage.

For suspected breast malignancies and axillary lymph node biopsies, consistent marker visibility is critical – from biopsy through post-NACT to surgery.

The HydroMARK™ Plus marker is designed to support reliable localization throughout the entire treatment pathway:

- At biopsy
-- Winged marker design enhances immediate visibility and helps secure the marker in the tissue[1, 2]

- Post-NACT
-- Hydrogel expands up to 200% within 24 hours, delivering strong, long-term ultrasound visibility for up to 12 months[3, 4]

- At surgery
-- Supports easier ultrasound localization, helping streamline procedures and improve patient comfort[4,5]

With Wings that Cling™ technology, the HydroMARK™ Plus marker is built for confidence across every step in your patients’ journey.

Find out more about the HydroMARK™ Plus markers: https://ow.ly/KF6s50ZiSlo

1. Compared to original HydroMARK™ markers.
2. HydroMARK™ Plus Device Test - PCR-000299, SDR0098 Vacuum Suction Testing
3. HydroMARK™ Device Test - ES-002128.
4. Sakamoto N, Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker. Breast Cancer. 2018 Sep;25(5):575-582.
5. Gentile, Ann Surg Oncol. 2016 Oct;23(10):3284-9. doi: 10.1245/s10434-016-5325-x. Epub 2016 Jun 23.

Address

300 E. Business Way, Suite 500
Cincinnati, OH
45241

Telephone

(877) 926-2666

Website

Alerts

Be the first to know and let us send you an email when Mammotome posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share